Charis Eng
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism 46
- Cancer Genomics and Diagnostics 39
- Endocrinology, Diabetes and Metabolism top 0.05%
- Thyroid Cancer Diagnosis and Treatment 43
- Oncology top 0.1%
- Cancer-related Molecular Pathways 43
- Molecular Biology top 0.05%
- PI3K/AKT/mTOR signaling in cancer 217
- Pathology and Forensic Medicine top 0.05%
- Genetic factors in colorectal cancer 65
-
- BRCA gene mutations in cancer 62
-
- Neuroendocrine Tumor Research Advances 43
- Co-authors
- Kristin WaiteLois M. MulliganJessica L. MesterPatricia L. M. DahiaDeborah J. MarshHartmut P.H. NeumannMohammed S. OrloffJoanne Ngeow
- Journals
- Human Molecular Genetics (41 papers)The Journal of Clinical Endocrinology & Metabolism (36 papers)The American Journal of Human Genetics (27 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Charis Eng
625 papers receiving 43.8k citations
Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 8.3k
- Endocrinology, Diabetes and Metabolism 8.4k
- Oncology 9.8k
- Molecular Biology 24.0k
- Pathology and Forensic Medicine 5.7k
Countries citing papers authored by Charis Eng
This map shows the geographic impact of Charis Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis Eng more than expected).
Fields of papers citing papers by Charis Eng
This network shows the impact of papers produced by Charis Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis Eng. The network helps show where Charis Eng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charis Eng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 20 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 10 | |
| 6 | 2014 | 38 | |
| 7 | 2013 | 26 | |
| 8 | 2013 | 20 | |
| 9 | 2013 | 113 | |
| 10 | 2012 | 22 | |
| 11 | 2012 | 34 | |
| 12 | 2010 | 54 | |
| 13 | 2009 | 26 | |
| 14 | 2008 | 275 | |
| 15 | 2007 | 74 | |
| 16 | 2006 | 153 | |
| 17 | 2006 | 237 | |
| 18 | 2004 | 111 | |
| 19 | 1998 | 14 | |
| 20 | 1998 | 12 |
About Charis Eng
Charis Eng is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 647 papers that have together received 44.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (217 papers), Genetic factors in colorectal cancer (65 papers), BRCA gene mutations in cancer (62 papers), Cancer, Hypoxia, and Metabolism (46 papers), Cancer-related Molecular Pathways (43 papers), Neuroendocrine Tumor Research Advances (43 papers), Thyroid Cancer Diagnosis and Treatment (43 papers) and Cancer Genomics and Diagnostics (39 papers). The work is most often cited by research in Cancer Research (8.3k citations), Endocrinology, Diabetes and Metabolism (8.4k citations) and Oncology (9.8k citations). Charis Eng has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kristin Waite, Lois M. Mulligan, Jessica L. Mester, Patricia L. M. Dahia, Deborah J. Marsh, Hartmut P.H. Neumann, Mohammed S. Orloff, Joanne Ngeow, Catherine S. Healey and Ramon Parsons. Their work appears in journals such as Human Molecular Genetics, The Journal of Clinical Endocrinology & Metabolism, The American Journal of Human Genetics, Journal of Clinical Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.